These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 9149125)

  • 21. Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas.
    Elisei R; Shiohara M; Koeffler HP; Fagin JA
    Cancer; 1998 Nov; 83(10):2185-93. PubMed ID: 9827724
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mutational analysis of the p16 gene in human neuroblastomas.
    Castresana JS; Gómez L; García-Miguel P; Queizán A; Pestaña A
    Mol Carcinog; 1997 Mar; 18(3):129-33. PubMed ID: 9115582
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Sporadic CDKN2 (MTS1/p16ink4) gene alterations in human ovarian tumours.
    Schuyer M; van Staveren IL; Klijn JG; vd Burg ME; Stoter G; Henzen-Logmans SC; Foekens JA; Berns EM
    Br J Cancer; 1996 Oct; 74(7):1069-73. PubMed ID: 8855976
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mutation profile of the p53, fhit, p16INK4a/p19ARF and H-ras genes in Indian breast carcinomas.
    Kannan K; Krishnamurthy J; Feng J; Nakajima T; Tsuchida N; Shanmugam G
    Int J Oncol; 2000 Nov; 17(5):1031-5. PubMed ID: 11029509
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Screening of germline mutations in the CDKN2A and CDKN2B genes in Swedish families with hereditary cutaneous melanoma.
    Platz A; Hansson J; Månsson-Brahme E; Lagerlof B; Linder S; Lundqvist E; Sevigny P; Inganäs M; Ringborg U
    J Natl Cancer Inst; 1997 May; 89(10):697-702. PubMed ID: 9168184
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Investigations to the influence of tumor supressor gene p16 inactivation on the prognosis of head and neck squamous cell carcinoma].
    Koscielny S; V Eggeling F; Dahse R
    Laryngorhinootologie; 2004 Jun; 83(6):374-80. PubMed ID: 15197677
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymorphisms and mutations found in the regions flanking exons 5 to 8 of the TP53 gene in a population at high risk for esophageal cancer in South Africa.
    Vos M; Adams CH; Victor TC; van Helden PD
    Cancer Genet Cytogenet; 2003 Jan; 140(1):23-30. PubMed ID: 12550754
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mutations of the INK4a locus in squamous cell carcinomas of human skin.
    Kubo Y; Urano Y; Matsumoto K; Ahsan K; Arase S
    Biochem Biophys Res Commun; 1997 Mar; 232(1):38-41. PubMed ID: 9125147
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mechanism of inactivation of CDKN2 and MTS2 in non-small cell lung cancer and association with advanced stage.
    Nakagawa K; Conrad NK; Williams JP; Johnson BE; Kelley MJ
    Oncogene; 1995 Nov; 11(9):1843-51. PubMed ID: 7478613
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence of gene deletion of p21 (WAF1/CIP1), a cyclin-dependent protein kinase inhibitor, in thyroid carcinomas.
    Shi Y; Zou M; Farid NR; al-Sedairy ST
    Br J Cancer; 1996 Nov; 74(9):1336-41. PubMed ID: 8912526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The correlation between alteration of p16 gene and clinical status in oral squamous cell carcinoma.
    Tsai CH; Yang CC; Chou LS; Chou MY
    J Oral Pathol Med; 2001 Oct; 30(9):527-31. PubMed ID: 11555154
    [TBL] [Abstract][Full Text] [Related]  

  • 32. No point mutation but decreased expression of the p16/MTS1 tumor suppressor gene in nasopharyngeal carcinomas.
    Sun Y; Hildesheim A; Lanier AE; Cao Y; Yao KT; Raab-Traub N; Yang CS
    Oncogene; 1995 Feb; 10(4):785-8. PubMed ID: 7862458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inactivation of the CDKN2 gene by homozygous deletion and de novo methylation is associated with advanced stage esophageal squamous cell carcinoma.
    Maesawa C; Tamura G; Nishizuka S; Ogasawara S; Ishida K; Terashima M; Sakata K; Sato N; Saito K; Satodate R
    Cancer Res; 1996 Sep; 56(17):3875-8. PubMed ID: 8752149
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutational analysis of the PTEN/MMAC1 gene in primary oesophageal squamous cell carcinomas.
    Hu YC; Lam KY; Tang JC; Srivastava G
    Mol Pathol; 1999 Dec; 52(6):353-6. PubMed ID: 10748870
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genomic instability, mutations and expression analysis of the tumour suppressor genes p14(ARF), p15(INK4b), p16(INK4a) and p53 in actinic keratosis.
    Kanellou P; Zaravinos A; Zioga M; Stratigos A; Baritaki S; Soufla G; Zoras O; Spandidos DA
    Cancer Lett; 2008 Jun; 264(1):145-61. PubMed ID: 18331779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Coincidental alterations of p16INK4A/CDKN2 and other genes in human lung cancer cell lines.
    Fujishita T; Mizushima Y; Kashii T; Kobayashi M
    Anticancer Res; 1998; 18(3A):1537-42. PubMed ID: 9673367
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gene mutations in esophageal mucosa of chagas disease patients.
    DA Silva Manoel-Caetano F; Silveira AF; Silva AE
    Anticancer Res; 2009 Apr; 29(4):1243-7. PubMed ID: 19414370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutations of the cell cycle regulatory genes p16INK4A and p21WAF1 and the metastasis-inducing gene S100A4 are infrequent and unrelated to p53 tumour suppressor gene status and data on survival in oropharyngeal squamous cell carcinomas.
    Ibrahim SO; Lillehaug JR; Vasstrand EN
    Anticancer Res; 2003; 23(6C):4593-600. PubMed ID: 14981901
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infrequent p16/CDKN2 alterations in squamous cell carcinoma of the oesophagus.
    Giroux MA; Audrezet MP; Metges JP; Lozac'h P; Volant A; Nousbaum JB; Labat JP; Gouérou H; Ferec C; Robaszkiewicz M
    Eur J Gastroenterol Hepatol; 2002 Jan; 14(1):15-8. PubMed ID: 11782570
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Absence of deletions but frequent loss of expression of p16INK4 in human ovarian tumours.
    Marchini S; Codegoni AM; Bonazzi C; Chiari S; Broggini M
    Br J Cancer; 1997; 76(2):146-9. PubMed ID: 9231912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.